Mass versus molar doses, similarities and differences

被引:5
作者
Chmielewska, A. [1 ]
Lamparczyk, H. [1 ]
机构
[1] Med Acad Gdansk, Fac Pharm, PL-80416 Gdansk, Poland
来源
PHARMAZIE | 2008年 / 63卷 / 11期
关键词
D O I
10.1691/ph.2008.8578
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Generally, they are two systems expressing the amounts of active substance in a given drug product, i.e. mass and molar dose. Currently, the dose system based on the mass is widely used in which doses are expressed in grams or milligrams. On the other hand, the molar dose system is in direct relation to the number of molecules. Hence, the objective of this work was to compare both systems in order to find their advantages and disadvantages. Active substances belonging to the groups of antibiotics, nootropic agents, beta-blockers, vitamins, GABA-analog, COX-2 inhibitors, calcium channel antagonists, benzodiazepine receptor agonists, lipid-modifying agents (fibrates), non-steroidal anti-inflammatory drugs (profens), estrogens, neuroleptics, analgesics and benzodiazepines were considered. Moreover, products containing two active substances were also taken into account. These are mixtures of hydrochlorothiazide with active substances influencing the renin-angiotensin system and combined oral contraceptives. For each active substance, belonging to the groups mentioned above molar doses were calculated from mass doses and molar mass. Hence, groups of drugs with a single active substance, drugs with similar pharmacological activities, pharmaceutical alternatives, and drugs with a single active ingredient manufactured in different doses were compared in order to find which dose system describes more adequately differences between and within the groups mentioned above. Comparisons were supported by a number of equations, which theoretically justify the data, and relationships derived from calculations.
引用
收藏
页码:843 / 848
页数:6
相关论文
共 25 条
  • [1] Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 μg ethinylestradiol and 3 mg drospirenone
    Bachmann, G
    Sulak, PJ
    Sampson-Landers, C
    Benda, N
    Marr, J
    [J]. CONTRACEPTION, 2004, 70 (03) : 191 - 198
  • [2] CHAMBERLAIN DA, 1976, BR MED J 1030, P1068
  • [3] Esomeprazole tablet vs omeprazole capsule in treating erosive esophagitis
    Chen, Chih-Yen
    Lu, Ching-Liang
    Luo, Jiing-Chyuan
    Chang, Full-Young
    Lee, Shou-Dong
    Lai, Yung-Ling
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (20) : 3112 - 3117
  • [4] Effect of air-pollution control on death rates in Dublin, Ireland: an intervention study
    Clancy, L
    Goodman, P
    Sinclair, H
    Dockery, DW
    [J]. LANCET, 2002, 360 (9341) : 1210 - 1214
  • [5] Tramadol SR formulations -: Pharmacokinetic comparison of a multiple-units dose (capsule) versus a single-unit dose (tablet)
    Cnota, PJ
    Nowak, H
    Tagarro, I
    Erb, K
    Schürer, M
    Schulz, HU
    Maus, J
    [J]. CLINICAL DRUG INVESTIGATION, 2005, 25 (07) : 435 - 443
  • [6] Effect of single wall carbon nanotubes on human HEK293 cells
    Cui, DX
    Tian, FR
    Ozkan, CS
    Wang, M
    Gao, HJ
    [J]. TOXICOLOGY LETTERS, 2005, 155 (01) : 73 - 85
  • [7] Short-term (13-week) toxicity study of 5-bromo-6-methoxy-5,6-dihydro-3′-azidothymidine-5′-(p-bromophenyl) methoxyalaninyl phosphate (WHI-07), a novel anti-HIV and contraceptive agent, in B6C3F1 mice
    D'Cruz, OJ
    Uckun, FM
    [J]. TOXICOLOGICAL SCIENCES, 2001, 60 (02) : 373 - 378
  • [8] The pinpoint promise of nanoparticle-based drug delivery and molecular diagnosis
    Emerich, Dwaine F.
    Thanos, Christopher G.
    [J]. BIOMOLECULAR ENGINEERING, 2006, 23 (04): : 171 - 184
  • [9] Evans AM, 1996, J CLIN PHARMACOL, V36, pS7
  • [10] EVALUATION OF CHROMATOGRAPHIC METHODS FOR THE DETERMINATION OF NIFEDIPINE IN HUMAN SERUM
    JANKOWSKI, A
    LAMPARCZYK, H
    [J]. JOURNAL OF CHROMATOGRAPHY A, 1994, 668 (02) : 469 - 473